Nano Dimension Ltd is trading 5.2% up at $1.31, staging a recovery following a sharp decline triggered by its unexpected strategic shift into health AI.
- The stock plummeted approximately 14–16% on June 15, 2026, after the company announced a non-binding stock-for-stock merger with Infinite Epigenetics.
- Today's price action reflects a partial relief rally as investors reassess the proposed merger and the company's radical change in business focus.